Indian biosimilar market to be worth $40 billion by 2030

~ Active engagement in Indian industry with about 70 approved biosimilars – Urgent need to expand markets & de-clog RoW market access to actualize potential for global leadership Chennai, 23, 2018: The Confederation of Indian Industry (CII) & Sathguru Management Consultants released a position paper on Indian Biosimilars Industry – “Indian Biosimilars Industry: Roadmap …